HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 5, 2010, Pages 774-780

  D'Avolio, Antonio ^a   Simiele, Marco ^a   Siccardi, Marco ^a   Baietto, Lorena ^a   Sciandra, Mauro ^a   Bonora, Stefano ^a   Di Perri, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antiretrovirals; Dry plasma spot; Filter; HPLC MS; Therapeutic drug monitoring

Indexed keywords

AMPRENAVIR; ATAZANAVIR; DARUNAVIR; EFAVIRENZ; ETRAVIRINE; LOPINAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD FILTER; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; QUANTITATIVE STUDY; SENSITIVITY AND SPECIFICITY; TEMPERATURE SENSITIVITY; THERMOSTABILITY; VALIDITY;

ANTI-HIV AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; MASS SPECTROMETRY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 77950863863     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.02.026     Document Type: Article

References (22)

1. FDA Web, Drugs Used in the Treatment of HIV Infection, <> (last access: 30.01.10). http://www.fda.gov/oashi/aids/virals.html.
2. Back D., Gatti G., Fletcher C., Garaffo R., Haubrich R., Hoetelmans R., Kurowski M., Luber A., Merry C., Perno C.F. Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS 2002, 16(Suppl. 1):S5-S37.
3. Back D., Gibbons S., Khoo S. An update on therapeutic drug monitoring for antiretroviral drugs. Ther. Drug Monit. 2006, 28:468-473.
4. Gazzard B. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). HIV Med. 2005, 6(Suppl. 2):1-61.
5. Gazzard B., Bernard A.J., Boffito M., Churchill D., Edwards S., Fisher N., Geretti A.M., Johnson M., Leen C., Peters B., Pozniak A., Ross J., Walsh J., Wilkins E., Youle M. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med. 2006, 7:487-503.
6. Allanson A.L., Cotton M.M., Tettey J.N.A., Boyter A.C. Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: a potential method for therapeutic drug monitoring. J. Pharm. Biomed. Anal. 2007, 44:963-969.
7. Hoogtanders K., van der Heijden J., Christiaans M., Edelbroek P., van Hooff J.P., Stolk L.M.L. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J. Pharm. Biomed. Anal. 2007, 44:658-664.
8. Hoogtanders K., van der Heijden J., Christiaans M., van de Plas A., van Hooff J., Stolk L. Dried blood spot measurement of tacrolimus is promising for patient monitoring. Transplantation 2007, 83:237-238.
9. Blessborn D., Romsing S., Annerberg A., Sundquist D., Bjorkman A., Lindegardh N., Bergqvist Y. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. J. Pharm. Biomed. Anal. 2007, 45:282-287.
10. Gitau E.N., Muchohi S.N., Ogutu B.R., Githiga I.M., Kokwaro G.O. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2004, 799:173-177.
11. Koal T., Burhenne H., Romling R., Svoboda M., Resch K., Kaever V. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19:2995-3001.
12. Ter H.R., Rosing H., van Gorp E.C., Mulder J.W., Beijnen J.H., Huitema A.D. Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. J. Pharm. Biomed. Anal. 2009, 49:393-400.
13. Ter H.R., Rosing H., van Gorp E.C., Mulder J.W., van der Steeg W.A., Beijnen J.H., Huitema A.D. Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 867:205-212.
14. Ter H.R., Hillebrand M.J., Rosing H., van Gorp E.C., Mulder J.W., Beijnen J.H., Huitema A.D. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. J. Pharm. Biomed. Anal. 2009, 49:451-458.
15. Kappelhoff B.S., Crommentuyn K.M., de Maat M.M., Mulder J.W., Huitema A.D., Beijnen J.H. Practical guidelines to interpret plasma concentrations of antiretroviral drugs. Clin. Pharmacokinet. 2004, 43:845-853.
16. D'Avolio A., Siccardi M., Sciandra M., Baietto L., Bonora S., Trentini L., Di Perri G. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients (vol. 859, p. 234, 2007). J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 862:265.
17. Taylor P.J. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 2005, 38:328-334.
18. Center for Drug Evaluation and Research of the U.S.Department of Health and Human Services Food and Drug Administration Guidance for Industry Bioanalytical Method Validation 2001, FDA.
19. D'Avolio A., Baietto L., Siccardi M., Sciandra M., Simiele M., Oddone V., Bonora S., Di Perri G. An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. Ther. Drug Monit. 2008, 30:662-669.
20. KKGT Web, International Interlaboratory Control Program for Therapeutic Drug Monitoring in HIV Infection, <> (last access: 30.01.10). http://www.kkgt.nl/.
21. D'Avolio A., Sciandra M., Siccardi M., Baietto L., de Requena D.G., Bonora S., Di Perri G. A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 848:374-378.
22. TDM Torino Web, Therapeutic Drug Monitoring-Web Site, Laboratory of Clinical Pharmacology and Pharmacogenetics, University of Turin/ASL TO2, <> (last access: 30.01.10). http://www.tdm-torino.org/.